...BRCA1/2 genes have been associated with prostate cancer risk and prognosis. We describe the prostate cancer screening ch...
...BRCA1, we replace a six-base-pair (bp) genomic region with all possible hexamers, or the full exon with all possible sin...
...BRCA1 tumor suppressors. Next, PALB2 interacts with BRCA2, which is a tumor suppressor, and with the RAD51 recombinase. ...
...BRCA1 (BRCA1 group) and BRCA2 (BRCA2 group) mutations.,We retrospectively reviewed the medical records of patients with ...
...BRCA1/2 -negative breast and/or ovarian cancer families to a) assess the contribution of PALB2 mutations in this series ...
The screening of BRCA1 and BRCA2 mutations is now an established component of risk evaluation and management of familial...
...BRCA1-negative, BRCA2-negative, PIK3CA mutation (p.His1047Arg) positive presented with diffuse bony metastases and bone ...
Several proteins in the BRCA-Fanconi anemia (FA) pathway, such as FANCJ, BRCA1, and FANCD2, interact with mismatch repai...
...BRCA1 or BRCA2 genes a new and in many cases effective option for disease control. There is potentially a large patient ...
...BRCA1 C-terminal domain) acts as a strong transcriptional activator. BRCA1 damaged by carboplatin treatment may lead to ...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
